Revolutionizing Medicine Production with Continuous Flow Chemistry
About this episode
Modern drugs depend on safe, efficient, and sustainable chemical manufacturing processes. However, traditional batch synthesis methods often involve hazardous intermediates and complex steps, are vulnerable to global supply chain disruption and pose risks to workers and the environment. To address this, Dr. Patrick O’Neill of Pfizer, Ireland, and Professor Jie Wu from the National University of Singapore, alongside their teams, have pioneered a revolutionary method to synthesize 1,2,3-triazole, a key compound used to manufacture the vital antibiotic tazobactam.
Original Article Reference
Summary of the paper: ‘1,2,3-Triazole Synthesis: Development of Safe and Effective Batch and Continuous Manufacturing Processes’, in Organic Process Research & Development, doi.org/10.1021/acs.oprd.4c00020
Contact
For further information, you can connect with Dr Pat O’Neill at pat.o’neill@pfizer.com
What does this mean?
Share: You can copy and redistribute the material in any medium or format
Adapt: You can change, and build upon the material for any purpose, even commercially.
Credit: You must give appropriate credit, provide a link to the license, and indicate if changes were made.